Programmed cell death 4 protein in esophageal cancer

  • Authors:
    • Matteo Fassan
    • Matteo Cagol
    • Gianmaria Pennelli
    • Christian Rizzetto
    • Luciano Giacomelli
    • Giorgio Battaglia
    • Giovanni Zaninotto
    • Ermanno Ancona
    • Alberto Ruol
    • Massimo Rugge
  • View Affiliations

  • Published online on: July 1, 2010     https://doi.org/10.3892/or_00000838
  • Pages: 135-139
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Screening for genes down-regulated in esophageal cancers (Oncomine database) pinpointed programmed cell death 4 (PDCD4) as one of the most consistently involved. PDCD4 is a new putative tumor suppressor gene implicated in cell transformation, tumorigenesis, and invasiveness. Based on such a biological rationale, the aim of the present study was to evaluate the prognostic value of PDCD4 in esophageal cancers. The immunohistochemical expression of PDCD4 protein was assessed in 111 consecutive esophageal cancers (63 adenocarcinomas and 48 squamous cell carcinomas) and paired non-cancerous samples. PDCD4 immunostaining was significantly lower in cancer samples than in non-cancerous mucosa (p<0.001). In all cases, the native esophageal epithelium consistently expressed nuclear PDCD4, which was significantly less expressed (37/111 cases) or completely lacking (31/111 cases) in the cancer samples. A significant inverse correlation emerged between nuclear PDCD4 expression and tumor stage (p=0.002), pT (p<0.001), nodal metastasis (p=0.038), and with both vascular (p=0.005) and perineural invasion (p=0.004). Nuclear PDCD4 expression was associated with a longer disease-free (p=0.011) and overall (p=0.021) survival. PDCD4 expression predicts the patient outcome in esophageal cancers. Additional functional studies should look into the role of PDCD4 in the multistep process of esophageal oncogenesis also inquiring on the clinical usefulness of the protein expression as prognostic marker in esophageal precancerous lesions.

Related Articles

Journal Cover

July 2010
Volume 24 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fassan M, Cagol M, Pennelli G, Rizzetto C, Giacomelli L, Battaglia G, Zaninotto G, Ancona E, Ruol A, Rugge M, Rugge M, et al: Programmed cell death 4 protein in esophageal cancer. Oncol Rep 24: 135-139, 2010
APA
Fassan, M., Cagol, M., Pennelli, G., Rizzetto, C., Giacomelli, L., Battaglia, G. ... Rugge, M. (2010). Programmed cell death 4 protein in esophageal cancer. Oncology Reports, 24, 135-139. https://doi.org/10.3892/or_00000838
MLA
Fassan, M., Cagol, M., Pennelli, G., Rizzetto, C., Giacomelli, L., Battaglia, G., Zaninotto, G., Ancona, E., Ruol, A., Rugge, M."Programmed cell death 4 protein in esophageal cancer". Oncology Reports 24.1 (2010): 135-139.
Chicago
Fassan, M., Cagol, M., Pennelli, G., Rizzetto, C., Giacomelli, L., Battaglia, G., Zaninotto, G., Ancona, E., Ruol, A., Rugge, M."Programmed cell death 4 protein in esophageal cancer". Oncology Reports 24, no. 1 (2010): 135-139. https://doi.org/10.3892/or_00000838